 Citybizlist |
Targacept CEO steps down, leaves board
BusinessWeek The departure comes as the company has slashed its work force to cut costs after ending development of an experimental depression drug and setbacks in tests of another drug to treat asthma and diabetes. Its shares are down more than 80 percent in the … Biopharma company Targacept says CEO resigns Targacept's CEO stepping down in reshuffle |
View full post on asthma – Google News